NPN Log

Hyderabad: Aurobindo Pharma has announced a consolidated net profit of ₹921 crore for the quarter ending in March of the last financial year (2025-26). Compared to the corresponding period of the previous financial year, the profit witnessed a marginal growth of 2 percent. During the quarter under review, total revenue also grew by 5.6 percent, rising from ₹8,382 crore to ₹8,853 crore. **Fire Engulfs Shapoorji Pallonji Pipes**

You Might Also Like

Comments

Leave A Comment

Don’t worry ! Your email address will not be published. Required fields are marked (*).